Companion Medical announced that it has received clearance from the Food and Drug Administration (FDA) for a new bolus calculator for fixed dosing and meal estimation to be used with the InPen system.

A recent study published in the BMC Medicine medical journal concluded that smartphone apps that offer an insulin dose calculator may actively contribute to incorrect dose recommendations, according ...

INDIANAPOLIS — Roche on Tuesday announced that the Accu-Chek Aviva Expert system is now available by prescription. The device represents a significant advancement in blood-glucose meter technology for ...

Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's ...

Insulin dosage is an ongoing area of interest among digital health companies. Initiating and increasing insulin dosages represent some of the greatest challenges to help Type 2 diabetes patients ...

CHARLOTTE, N.C., June 20 - MD Scientific, LLC (MD Scientific), announces Food and Drug Administration clearance to market EndoTool(TM) Glucose Management System. EndoTool(TM) is an intravenous insulin ...

Patients with mainly type 1 diabetes who require multiple daily insulin injections may benefit from a new device — a blood glucose meter with a built-in insulin bolus calculator or "advisor" — a ...

Study Raises Concerns About Accuracy of Insulin Dosing Apps The study, conducted by the Global eHealth Unit at the Imperial College London, has found that the majority of insulin dosing apps are ...

Patients with diabetes who use Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems can now better manage their blood glucose levels with a new method for leveraging the trend arrows ...

(HealthDay)—Cardiovascular outcomes in patients with diabetes are not explained by insulin resistance, according to research published online Sept. 12 in Diabetes, Obesity and Metabolism. Hertzel C.

(HealthDay News) — Cardiovascular outcomes in patients with diabetes are not explained by insulin resistance, according to research published online in Diabetes, Obesity and Metabolism. Hertzel C.